“R.itemList.length” “- this.config.text.ariaShown
“This.config.text.ariaFermé”
The “HIV Testing (In vitro Diagnostics) – Global Market Forecasting and Analysis Model (COVID-19 Market Impact)” has been added to the ResearchAndMarkets.com offering.
This report is designed to visualize quantitative market trends in the cure box of in vitro diagnostics. The style takes a closer look at the effect of COVID-19 on the HIV testing market by 2020 and beyond.
HIV is an ongoing global public aptitude challenge that remains a top precedent for top governments. HIV testing is performed for two purposes: (i) testing and diagnosis; or (ii) follow-up of HIV-positive patients, especially those on antiretroviral processing (ART).
HIV testing for pregnant women is the most popular care in most countries and is considered a cost-effective strategy to reduce the threat of transmission to the baby. Women are screened regularly during the first trimester of pregnancy. For pregnant women most at the highest risk of HIV, tests are repeated infrequently at the beginning of the third trimester (28 weeks) or at the time of delivery. HIV diagnostic tests come with POC, NAAT, multiparametric NAAT, and EIA. HIV surveillance tests come with TAAN for viral load testing and CD4 counting.
Each of the color-coded market models, fully provided in 39 covered countries, is provided with epidemiological indications with procedural volumes. To build knowledge transparency, Excel’s interactive deliverable covers the installed base, new sales volumes, product usage, average promotion prices, market location length and company share/classification research (if applicable). In addition, analyst feedback with qualitative data provides context for quantitative knowledge.
The market style inclusions are:
HIV lately in the market and turning the competitive landscape.
A detailed review of key trends.
Total annualized benefit of the HIV market through the segment and market outlook from 2015 to 2030.
Granular knowledge of general procedures, units, average promotion and market values across the segment.
Information to the global, regional and national market.
Market-specific qualitative data are available, with global trends that are then transformed into regional trends. In addition, publisher analysts provide market-specific data.
SDSA research for the HIV market.
Information and trends on competitive dynamics provided for the HIV market.
Improve market placement by getting a true review by adding a fitness care system review. In addition, the market access segment allows you to deepen market location dynamics with data on repayment policies and the regulatory landscape.
Summary of the national care formula.
Country specific reimbursement policies.
The regulatory landscape of medical technology at the national level.
Strong methodologies and resources allow the style to generate a thorough and accurate review of the market. Primary source and application resources are incorporated into unionized styles, adding key opinion leaders. In addition, genuine knowledge resources are used to market trends; they come with knowledge bases on government procedures, knowledge bases on hospital purchases, and patented online knowledge bases.
Covered countries: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
Reasons to buy
The style will allow you to:
Understand that they have an effect of COVID-19 on the HIV testing market.
Develop and design your accreditation and license through product and pipeline technology review, and identify corporations with the most powerful pipeline.
Develop business methods through trends that shape and stimulate the HIV testing market.
Generate profits by understanding key trends, cutting-edge products and technologies, market segments, and corporations that may have an effect on the HIV testing market in the future.
Develop effective sales and marketing methods through the competitive landscape and analyze the percentage of company leaders in the market.
Identify emerging players with potential product portfolios and create effective counter-strategies to gain a competitive edge.
Track device sales in the global and country-specific HIV market from 2015 to 2030.
Organize your sales and marketing efforts by identifying categories and market segments that offer maximum opportunities for consolidation, investment, and strategic partnerships.
Companies mentioned
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Siemens Healthineers AG
Bio-Rad Laboratories Inc.
Becton Dickinson and Co.
OraSure Inc. Technologies
For more information about this report, https://www.researchandmarkets.com/r/6zdsj5
See the businesswire.com edition: https://www.businesswire.com/news/home/20200806005446/fr/
Contacts
ResearchAndMarkets.com Laura Wood, Senior Press [email protected] For E. S.T., 1-917-300-0470 For USA/ CAN, toll-free 1-800-526-8630